CD34 and Schnyder corneal dystrophy: Vectors carrying the βAS3-globin transgene corrected hematologic and clinical findings in the Townes Sickle Cell mouse model, and were also shown to transduce SCD patient BM CD34+ cells and induce therapeutic levels of HbAAS3–globin to correct red blood cell (RBC) physiology.11